JP2002501085A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501085A5
JP2002501085A5 JP2000528602A JP2000528602A JP2002501085A5 JP 2002501085 A5 JP2002501085 A5 JP 2002501085A5 JP 2000528602 A JP2000528602 A JP 2000528602A JP 2000528602 A JP2000528602 A JP 2000528602A JP 2002501085 A5 JP2002501085 A5 JP 2002501085A5
Authority
JP
Japan
Prior art keywords
antibody
human
heterodimer
subunit
hybridoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000528602A
Other languages
English (en)
Japanese (ja)
Other versions
JP4481489B2 (ja
JP2002501085A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/000202 external-priority patent/WO1999037682A2/en
Publication of JP2002501085A publication Critical patent/JP2002501085A/ja
Publication of JP2002501085A5 publication Critical patent/JP2002501085A5/ja
Application granted granted Critical
Publication of JP4481489B2 publication Critical patent/JP4481489B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000528602A 1998-01-23 1999-01-15 ヒトil−12に対する抗体 Expired - Fee Related JP4481489B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7233398P 1998-01-23 1998-01-23
US60/072,333 1998-01-23
PCT/EP1999/000202 WO1999037682A2 (en) 1998-01-23 1999-01-15 Antibodies against human il-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009098976A Division JP2009197008A (ja) 1998-01-23 2009-04-15 ヒトil−12に対する抗体

Publications (3)

Publication Number Publication Date
JP2002501085A JP2002501085A (ja) 2002-01-15
JP2002501085A5 true JP2002501085A5 (cg-RX-API-DMAC7.html) 2006-03-02
JP4481489B2 JP4481489B2 (ja) 2010-06-16

Family

ID=22106938

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000528602A Expired - Fee Related JP4481489B2 (ja) 1998-01-23 1999-01-15 ヒトil−12に対する抗体
JP2009098976A Withdrawn JP2009197008A (ja) 1998-01-23 2009-04-15 ヒトil−12に対する抗体
JP2013029936A Pending JP2013139458A (ja) 1998-01-23 2013-02-19 ヒトil−12に対する抗体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009098976A Withdrawn JP2009197008A (ja) 1998-01-23 2009-04-15 ヒトil−12に対する抗体
JP2013029936A Pending JP2013139458A (ja) 1998-01-23 2013-02-19 ヒトil−12に対する抗体

Country Status (18)

Country Link
US (1) US6225117B1 (cg-RX-API-DMAC7.html)
EP (2) EP1049717B1 (cg-RX-API-DMAC7.html)
JP (3) JP4481489B2 (cg-RX-API-DMAC7.html)
KR (1) KR100764256B1 (cg-RX-API-DMAC7.html)
CN (2) CN101274962A (cg-RX-API-DMAC7.html)
AR (2) AR014459A1 (cg-RX-API-DMAC7.html)
AT (2) ATE553129T1 (cg-RX-API-DMAC7.html)
AU (1) AU759624B2 (cg-RX-API-DMAC7.html)
BR (1) BR9907743A (cg-RX-API-DMAC7.html)
CA (1) CA2318052C (cg-RX-API-DMAC7.html)
CY (2) CY1106594T1 (cg-RX-API-DMAC7.html)
DE (1) DE69935574T2 (cg-RX-API-DMAC7.html)
DK (2) DK1049717T3 (cg-RX-API-DMAC7.html)
ES (2) ES2284242T3 (cg-RX-API-DMAC7.html)
PT (2) PT1049717E (cg-RX-API-DMAC7.html)
TR (1) TR200002145T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999037682A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA99452B (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399379B1 (en) 1992-09-29 2002-06-04 Isis Pharmaceuticals, Inc. Antisense modulation of interleukin 12 p35 subunit expression
WO2003104495A1 (en) * 2002-06-11 2003-12-18 Isis Pharmaceuticals, Inc. METHODS FOR BLOCKING ADIPOCYTE DIFFERENTIATION AND TRIGLYCERIDE ACCUMULATION WITH INTERLEUKIN 12 p35 INHIBITORS
US6706264B1 (en) 1994-03-14 2004-03-16 Genetics Institute, Llc Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y
ZA95960B (en) * 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
US7026456B1 (en) * 1998-01-23 2006-04-11 Hoffman-La Roche, Inc. Antibodies against human IL-12
US6448081B1 (en) 2001-05-07 2002-09-10 Isis Pharmaceuticals, Inc. Antisense modulation of interleukin 12 p40 subunit expression
DK1137766T3 (da) * 1998-12-09 2006-01-30 Protein Design Labs Inc Anvendelse af IL-12-antistoffer til behandling af psoriasis
US6914128B1 (en) 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
US7883704B2 (en) 1999-03-25 2011-02-08 Abbott Gmbh & Co. Kg Methods for inhibiting the activity of the P40 subunit of human IL-12
US6939545B2 (en) * 1999-04-28 2005-09-06 Genetics Institute, Llc Composition and method for treating inflammatory disorders
EP1259544B1 (en) * 2000-02-11 2011-08-24 Biogen Idec MA Inc. Heterologous polypeptide of the tnf family
US6348316B1 (en) 2000-04-12 2002-02-19 Cedars-Sinai Medical Center Genetic testing for determining the risk of pouchitis development
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
US7638604B2 (en) * 2001-02-23 2009-12-29 Genetics Institute, Llc Monoclonal antibodies against interleukin-22
WO2002097048A2 (en) * 2001-05-30 2002-12-05 Centocor, Inc. ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
KR100453877B1 (ko) * 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
CA2512138C (en) * 2002-12-30 2013-07-16 Biogen Idec Ma Inc. Kim-1 antagonists and use to modulate immune system
EP1711527A4 (en) * 2003-12-15 2008-09-03 Dendreon Corp HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS
GB0329146D0 (en) * 2003-12-16 2004-01-21 Glaxosmithkline Biolog Sa Vaccine
CA2591813A1 (en) 2004-12-21 2006-06-29 Centocor, Inc. Anti-il-12 antibodies, epitopes, compositions, methods and uses
EP1865985B1 (en) 2005-03-02 2010-08-25 Biogen Idec MA Inc. Kim-1 antibodies for treatment of th2-mediated conditions
CN103145837A (zh) * 2005-06-30 2013-06-12 Abbvie公司 Il-12/p40结合蛋白
TWI417301B (zh) 2006-02-21 2013-12-01 Wyeth Corp 對抗人類介白素-22(il-22)之抗體及其用途
TW200744634A (en) * 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
WO2008088823A2 (en) 2007-01-16 2008-07-24 Abbott Laboratories Methods for treating psoriasis
CA2681752A1 (en) 2007-03-29 2008-10-09 Abbott Laboratories Crystalline anti-human 1l-12 antibodies
KR20100126515A (ko) 2008-03-18 2010-12-01 아보트 러보러터리즈 건선의 치료방법
MX2011001409A (es) 2008-08-14 2011-03-29 Cephalon Australia Pty Ltd Anticuerpos anti-il-12/il-23.
MX2011005672A (es) * 2008-11-28 2011-06-20 Abbott Lab Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
AU2010291927A1 (en) * 2009-09-14 2012-04-12 AbbVie Deutschland GmbH & Co. KG Methods for treating psoriasis
CN103275222B (zh) * 2013-05-15 2014-04-16 中山康方生物医药有限公司 一种阻断白介素12 p40功能的单克隆抗体及其编码基因和应用
EP3436477A2 (en) 2016-03-29 2019-02-06 Janssen Biotech, Inc. Method of treating psoriasis with increased interval dosing of anti-il12 and/or -23 antibody
TW201922780A (zh) * 2017-09-25 2019-06-16 美商健生生物科技公司 以抗il12/il23抗體治療狼瘡之安全且有效之方法
WO2019220412A2 (en) 2018-05-18 2019-11-21 Janssen Biotech, Inc. Safe and effective method of treating lupus with anti-il12/il23 antibody
HUE063462T2 (hu) 2018-09-24 2024-01-28 Janssen Biotech Inc A colitis ulcerosa kezelésének biztonságos és hatékony eljárása anti-IL12/IL23 antitesttel
EP3972690A4 (en) 2019-05-23 2023-07-05 Janssen Biotech, Inc. METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE USING COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF-ALPHA
CA3183927A1 (en) 2020-05-21 2021-11-25 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
US5780597A (en) 1989-12-22 1998-07-14 Hoffmann-La Roche Inc. Monoclonal antibodies to cytotoxic lymphocyte maturation factor
CA2125763C (en) * 1993-07-02 2007-08-28 Maurice Kent Gately P40 homodimer of interleukin-12
US5536657A (en) 1993-07-19 1996-07-16 Hoffmann-La Roche Inc. Recombinant DNA encoding human receptor for interleukin-12
ZA95960B (en) * 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
US7119248B1 (en) * 1994-04-12 2006-10-10 Miltenyi Biotec Gmbh Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
US5853721A (en) * 1995-01-31 1998-12-29 Hoffmann-La Roche Inc. Antibody to interleukin-12 receptor
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
US5809360A (en) * 1996-08-07 1998-09-15 Agfa Division - Bayer Corporation Cassette for storing and accessing plates within an automated plate handler
AU734758B2 (en) * 1997-04-01 2001-06-21 Sankyo Company Limited Anti-fas antibodies

Similar Documents

Publication Publication Date Title
CA2318052A1 (en) Antibodies against human il-12
AU2001295490B2 (en) Antibodies to human IL-1beta
EP1248804B2 (en) Recombinant antibodies to human interleukin-1 beta
CA2657763C (en) Anti-il-6 monoclonal antibodies and uses thereof
JP4954104B2 (ja) Il−5介在障害を治療および診断するための改良方法
DE69532889T2 (de) Interleukin-5-spezifische rekombinante antikörper
AU2001295490A1 (en) Antibodies to human IL-1beta
EP1163271A1 (en) Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
DE69535319T2 (de) Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
CA2795043A1 (en) Humanized il-25 antibodies
JPH06225788A (ja) 免疫グロブリンイソタイプに対する再形状化されたモノクローナル抗体
TWI918239B (zh) Gdf15中和抗體及其用途
HK1061403B (en) ANTIBODIES TO HUMAN IL-1β